Chromosomal transformation in donor cells following allogeneic bone marrow transplantation

被引:16
|
作者
Lang, Z
Dinndorf, P
Ladisch, S
Bayever, E
Reaman, G
机构
[1] Childrens Natl Med Ctr, Dept Hematol Oncol, Washington, DC 20010 USA
[2] Ctr Canc & Blood Disorders, Washington, DC USA
[3] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA
关键词
donor cell transformation; microsatellite analysis;
D O I
10.1038/sj.bmt.1704450
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We report here a monosomy 7 transformation of donor cells following matched-unrelated, same sex, allogeneic bone marrow transplantation in a patient with severe congenital aplastic anemia. A PCR technique was employed to amplify microsatellite markers on chromosome 7 to confirm donor/recipient identity. We found that the transformation of monosomy 7 occurred in previously genetically normal donor cells. This study suggests that the microenvironment of the bone marrow of our patient with severe congenital aplastic anemia may have played a critical role in the development of monosomy 7 of normal donor cells and we conclude that chromosomal microsatellite marker analysis can be a valuable tool for precise donor/recipient differentiation in engraftment monitoring.
引用
收藏
页码:1253 / 1256
页数:4
相关论文
共 50 条
  • [31] HYPERAMMONEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    TSE, N
    CEDERBAUM, S
    GLASPY, JA
    AMERICAN JOURNAL OF HEMATOLOGY, 1991, 38 (02) : 140 - 141
  • [32] Myocardial infarction following allogeneic bone marrow transplantation
    Wang, B
    Cao, LX
    Liu, HL
    Jiang, M
    Hu, LD
    BONE MARROW TRANSPLANTATION, 1996, 18 (02) : 479 - 480
  • [33] IMMUNORECONSTITUTION FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION USING DONOR BONE-MARROW PRETREATED WITH IMMUNOTOXIN-101
    SPURLL, GM
    FAUSER, AA
    BLUT, 1986, 53 (03): : 199 - 199
  • [34] Thrombotic microangiopathy following allogeneic bone marrow transplantation
    Takatsuka, H
    Takemoto, Y
    Okamoto, T
    Fujimori, Y
    Tamura, S
    Wada, H
    Okada, M
    Kanamaru, A
    Kakishita, E
    BONE MARROW TRANSPLANTATION, 1999, 24 (03) : 303 - 306
  • [35] ALLOGENEIC CANINE BONE MARROW TRANSPLANTATION FOLLOWING CYCLOPHOSPHAMIDE
    STORB, R
    EPSTEIN, RB
    RUDOLPH, RH
    THOMAS, ED
    TRANSPLANTATION, 1969, 7 (05) : 378 - &
  • [36] THE EFFECT OF DONOR LEUKOCYTE INFUSION IN PATIENTS WITH LEUKEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    FRASSONI, F
    FAGIOLI, F
    SESSAREGO, M
    GUALANDI, F
    VANLINT, MT
    LAMPARELLI, T
    OCCHINI, D
    FIGARI, O
    VALBONESI, M
    BACIGALUPO, A
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 712 - 712
  • [37] Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation
    Grandage, VL
    Cornish, JM
    Pamphilon, DH
    Potter, MN
    Steward, CG
    Oakhill, A
    Marks, DI
    BONE MARROW TRANSPLANTATION, 1998, 21 (07) : 687 - 690
  • [38] Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation
    VL Grandage
    JM Cornish
    DH Pamphilon
    MN Potter
    CG Steward
    A Oakhill
    DI Marks
    Bone Marrow Transplantation, 1998, 21 : 687 - 690
  • [39] Adoptive immunotherapy following allogeneic bone marrow transplantation (BMT) with donor lymphocytes depleted of CD8+ T cells
    Alyea, E
    Soiffer, R
    Murray, C
    BartettPandite, L
    Collins, H
    Pickett, C
    Wang, Y
    Chartier, S
    Anderson, K
    Ritz, J
    BLOOD, 1995, 86 (10) : 1158 - 1158
  • [40] Donor dendritic cells regulate immune reconstitution after allogeneic bone marrow transplantation.
    Li, JM
    Harris, W
    David, E
    Lonial, S
    Waller, N
    BLOOD, 2004, 104 (11) : 839A - 840A